pe
pep-05118 v1 CC-BY-SA-4.0

PYY2 blood-sugar & appetite peptide

Aims to act on the body's natural blood sugar and hunger control system, the same pathway used by drugs like Ozempic. Still experimental, not an approved medicine.

statuscomputed targetGLP-1R length33 aa refs1
metabolic
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 1.0
ipTM0.637
pTM0.755
avg pLDDT71.8
ranking score0.702
STRUCTURE · PEP-05118 × GLP-1R
ranking0.702
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence33 aa
15101520253033
MATVLLALLVY LGALVDAYPIK PEAPGEDAFLG
in the news 136 articles
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.6373433470726013 boltz-2
ranking score 0.702225923538208 boltz-2
structural qualityopenfold3
metricvaluenote
gpde1.305global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
Met-Ala-Thr-Val-Leu-Leu-Ala-Leu-Leu-Val-Tyr-Leu-Gly-Ala-Leu-Val-Asp-Ala-Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Phe-Leu-Gly
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). PYY2 blood-sugar & appetite peptide (pep-05118, v1). PeptideModel. https://peptidemodel.com/card/pep-05118
@peptide{pep05118,
  sequence = {MATVLLALLVYLGALVDAYPIKPEAPGEDAFLG},
  target   = {glp-1r},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
references 1 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use